900000000000489007: Concept inactivation indicator attribute value reference set (foundation metadata concept)

SNOMED CT Concept\SNOMED CT Model Component\Foundation metadata concept (foundation metadata concept)\Reference set\Attribute value type\Concept inactivation indicator reference set

Status: current, Not sufficiently defined by necessary conditions definition status (core metadata concept). Date: 31-Jan 2002. Module: SNOMED CT model component module (core metadata concept)

Descriptions:

Expanded Value Set

Outbound Relationships	Type	Target	Active	Characteristic	Refinability	Group	Values
Concept inactivation indicator reference set	Is a	Attribute value type	true	Inferred relationship	Some

Members	valueId
Benign tumor of posterior wall of oropharynx	A component has been made inactive because it duplicates another component of the same type. E.g. A description that duplicates another description or a concept that duplicates another concept.
Benign tumor of pyloric antrum	A component has been made inactive because it duplicates another component of the same type. E.g. A description that duplicates another description or a concept that duplicates another concept.
Benign tumor of pylorus	A component has been made inactive because it duplicates another component of the same type. E.g. A description that duplicates another description or a concept that duplicates another concept.
Benign tumor of sigmoid colon	A component has been made inactive because it duplicates another component of the same type. E.g. A description that duplicates another description or a concept that duplicates another concept.
Benign tumor of spinal cord	A component has been made inactive because it duplicates another component of the same type. E.g. A description that duplicates another description or a concept that duplicates another concept.
Benign tumor of splenic flexure	A component has been made inactive because it duplicates another component of the same type. E.g. A description that duplicates another description or a concept that duplicates another concept.
Benign tumor of supraglottis	A component has been made inactive because it duplicates another component of the same type. E.g. A description that duplicates another description or a concept that duplicates another concept.
Benign tumor of tail of pancreas	A component has been made inactive because it duplicates another component of the same type. E.g. A description that duplicates another description or a concept that duplicates another concept.
Benign tumor of thoracic part of esophagus	A component has been made inactive because it duplicates another component of the same type. E.g. A description that duplicates another description or a concept that duplicates another concept.
Benign tumor of tonsillar pillar	A component has been made inactive because it duplicates another component of the same type. E.g. A description that duplicates another description or a concept that duplicates another concept.
Benign tumor of transverse colon	A component has been made inactive because it duplicates another component of the same type. E.g. A description that duplicates another description or a concept that duplicates another concept.
Benign tumor of unknown origin or ill-defined site	Ambiguous
Benign tumor of upper third of esophagus	A component has been made inactive because it duplicates another component of the same type. E.g. A description that duplicates another description or a concept that duplicates another concept.
Benign tumor of vermilion border of lip	A component has been made inactive because it duplicates another component of the same type. E.g. A description that duplicates another description or a concept that duplicates another concept.
Benign tumor of vestibule of mouth	A component has been made inactive because it duplicates another component of the same type. E.g. A description that duplicates another description or a concept that duplicates another concept.
Benign tumour	A component has been made inactive because it duplicates another component of the same type. E.g. A description that duplicates another description or a concept that duplicates another concept.
Benign tumour of bone and articular cartilage	A component has been made inactive because it duplicates another component of the same type. E.g. A description that duplicates another description or a concept that duplicates another concept.
Benign tumour of craniopharyngeal duct	A component has been made inactive because it duplicates another component of the same type. E.g. A description that duplicates another description or a concept that duplicates another concept.
Benign tumour of eye	A component has been made inactive because it duplicates another component of the same type. E.g. A description that duplicates another description or a concept that duplicates another concept.
Benign tumour of ovary	A component has been made inactive because it duplicates another component of the same type. E.g. A description that duplicates another description or a concept that duplicates another concept.
Benign tumour of pylorus	A component has been made inactive because it duplicates another component of the same type. E.g. A description that duplicates another description or a concept that duplicates another concept.
Benign tumour of tonsil	A component has been made inactive because it duplicates another component of the same type. E.g. A description that duplicates another description or a concept that duplicates another concept.
Bennett respirator therapy	A component that fails to comply with the current editorial guidance.
Benorilate product	A component has been made inactive because it duplicates another component of the same type. E.g. A description that duplicates another description or a concept that duplicates another concept.
Benorylate 2g/5mL s/f suspension	Ambiguous
Benorylate [central nervous sytem use]	A component has been made inactive because it duplicates another component of the same type. E.g. A description that duplicates another description or a concept that duplicates another concept.
Benorylate [musculoskeletal use]	A component has been made inactive because it duplicates another component of the same type. E.g. A description that duplicates another description or a concept that duplicates another concept.
Benoxinate hydrochloride	A component has been made inactive because it duplicates another component of the same type. E.g. A description that duplicates another description or a concept that duplicates another concept.
Benoxinate hydrochloride 0.2% eye drops	A component that is no longer current, useful, appropriate or acceptable.
Benoxinate hydrochloride 0.4% eye drops	A component that is no longer current, useful, appropriate or acceptable.
Benoxinate hydrochloride+fluorescein sodium 0.3%/0.125% eye drops	A component that is no longer current, useful, appropriate or acceptable.
Benoxinate hydrochloride+fluorescein sodium 0.4%/0.25% ophthalmic solution	A component that is no longer current, useful, appropriate or acceptable.
Benperidol overdose of undetermined intent	A component has been made inactive because it duplicates another component of the same type. E.g. A description that duplicates another description or a concept that duplicates another concept.
Benperidol poisoning of undetermined intent	A component has been made inactive because it duplicates another component of the same type. E.g. A description that duplicates another description or a concept that duplicates another concept.
Benserazide + levodopa adverse reaction	Ambiguous
Bent bone dysplasia	Ambiguous
Bent grass pollen allergen	Ambiguous
Bentheim Black Pied pig breed	Moved elsewhere
Bentheimer Landschaf sheep breed	Moved elsewhere
Benton visual behavior test	Erroneous component (foundation metadata concept)
Bentonite	A component has been made inactive because it duplicates another component of the same type. E.g. A description that duplicates another description or a concept that duplicates another concept.
Bentonite - chemical	A component has been made inactive because it duplicates another component of the same type. E.g. A description that duplicates another description or a concept that duplicates another concept.
Bentonite powder	A component that fails to comply with the current editorial guidance.
Benzalkonium chloride (in water)	A component that is no longer current, useful, appropriate or acceptable.
Benzalkonium chloride	A component has been made inactive because it duplicates another component of the same type. E.g. A description that duplicates another description or a concept that duplicates another concept.
Benzalkonium chloride + oxyquinoline sulfate	A component that fails to comply with the current editorial guidance.
Benzalkonium chloride - chemical	A component has been made inactive because it duplicates another component of the same type. E.g. A description that duplicates another description or a concept that duplicates another concept.
Benzalkonium chloride+cetrimide	A component has been made inactive because it duplicates another component of the same type. E.g. A description that duplicates another description or a concept that duplicates another concept.
Benzamide derivative antipsychotic agent	A component that fails to comply with the current editorial guidance.
Benzamide derivative antipsychotic agent	A component that fails to comply with the current editorial guidance.
Benzathine penicillin - chemical	A component has been made inactive because it duplicates another component of the same type. E.g. A description that duplicates another description or a concept that duplicates another concept.
Benzathine penicillin allergy	Erroneous component (foundation metadata concept)
Benzene causing toxic effect	Ambiguous
Benzene hexachloride	A component has been made inactive because it duplicates another component of the same type. E.g. A description that duplicates another description or a concept that duplicates another concept.
Benzene hexachloride poisoning	A component has been made inactive because it duplicates another component of the same type. E.g. A description that duplicates another description or a concept that duplicates another concept.
Benzhexol 2mg/5mL conventional release oral solution	A component that is no longer current, useful, appropriate or acceptable.
Benzhexol 2mg/5mL s/f oral solution	A component that is no longer current, useful, appropriate or acceptable.
Benzhexol hydrochloride 5mg/5mL syrup	Ambiguous
Benzhexol hydrochloride product	A component has been made inactive because it duplicates another component of the same type. E.g. A description that duplicates another description or a concept that duplicates another concept.
Benzimidazole anthelmintic adverse reaction	Ambiguous
Benzimidazole with anthelmintic mechanism of action	Ambiguous
Benzimidazolinone derivative antipsychotic agent	A component that fails to comply with the current editorial guidance.
Benzimidazolinone derivative antipsychotic preparation	A component that fails to comply with the current editorial guidance.
Benzisoxazole derivative antipsychotic agent	A component that fails to comply with the current editorial guidance.
Benzisoxazole derivative antipsychotic agent	A component that is no longer current, useful, appropriate or acceptable.
Benzocaine	A component has been made inactive because it duplicates another component of the same type. E.g. A description that duplicates another description or a concept that duplicates another concept.
Benzocaine + butamben + tetracaine hydrochloride	A component that fails to comply with the current editorial guidance.
Benzocaine + butamben + tetracaine hydrochloride 14%ww/2%ww/2%ww aerosol	A component that fails to comply with the current editorial guidance.
Benzocaine + butamben + tetracaine hydrochloride 14%ww/2%ww/2%ww gel	A component that fails to comply with the current editorial guidance.
Benzocaine + butamben + tetracaine hydrochloride 14%ww/2%ww/2%ww liquid	A component that fails to comply with the current editorial guidance.
Benzocaine + butamben + tetracaine hydrochloride 14%ww/2%ww/2%ww ointment	A component that fails to comply with the current editorial guidance.
Benzocaine + trimethobenzamide hydrochlor 2%ww/100mg suppositories	A component that is no longer current, useful, appropriate or acceptable.
Benzocaine + trimethobenzamide hydrochloride 2%ww/100mg rectal suppositories	A component that is no longer current, useful, appropriate or acceptable.
Benzocaine - chemical	A component has been made inactive because it duplicates another component of the same type. E.g. A description that duplicates another description or a concept that duplicates another concept.
Benzocaine 1mg throat spray	A component that fails to comply with the current editorial guidance.
Benzocaine 20% gel	A component has been made inactive because it duplicates another component of the same type. E.g. A description that duplicates another description or a concept that duplicates another concept.
Benzocaine 20% ointment	A component that fails to comply with the current editorial guidance.
Benzocaine 20% otic drops	A component that is no longer current, useful, appropriate or acceptable.
Benzocaine compound 100mg lozenge	A component that fails to comply with the current editorial guidance.
Benzocaine compound injection solution BPC vial	Moved elsewhere
Benzocaine overdose of undetermined intent	A component has been made inactive because it duplicates another component of the same type. E.g. A description that duplicates another description or a concept that duplicates another concept.
Benzocaine poisoning of undetermined intent	A component has been made inactive because it duplicates another component of the same type. E.g. A description that duplicates another description or a concept that duplicates another concept.
Benzocaine+menthol 100mg/3mg compound lozenge	A component that fails to comply with the current editorial guidance.
Benzocaine+salicylamide 2%/5% gel	A component has been made inactive because it duplicates another component of the same type. E.g. A description that duplicates another description or a concept that duplicates another concept.
Benzocaine+salicylamide 2%/5% gel	A component has been made inactive because it duplicates another component of the same type. E.g. A description that duplicates another description or a concept that duplicates another concept.
Benzodiazepine antiepileptic	A component that fails to comply with the current editorial guidance.
Benzodiazepine antiepileptic	A component has been made inactive because it duplicates another component of the same type. E.g. A description that duplicates another description or a concept that duplicates another concept.
Benzodiazepine dependence	A component has been made inactive because it duplicates another component of the same type. E.g. A description that duplicates another description or a concept that duplicates another concept.
Benzodiazepine nucleus	A component has been made inactive because it duplicates another component of the same type. E.g. A description that duplicates another description or a concept that duplicates another concept.
Benzodiazepine poisoning NOS	Limited component (foundation metadata concept)
Benzodiazepine sedative	A component that fails to comply with the current editorial guidance.
Benzodiazepine sedative adverse reaction	Ambiguous
Benzodiazepine sedative allergy	Erroneous component (foundation metadata concept)
Benzoic AND/OR salicylic acid poisoning	A component that fails to comply with the current editorial guidance.
Benzoic acid	A component has been made inactive because it duplicates another component of the same type. E.g. A description that duplicates another description or a concept that duplicates another concept.
Benzoic acid - chemical	A component has been made inactive because it duplicates another component of the same type. E.g. A description that duplicates another description or a concept that duplicates another concept.
Benzoic acid allergy	Erroneous component (foundation metadata concept)
Benzoic acid and salicylic acid	Ambiguous
Benzoic acid or benzoic acid derivative	A component that fails to comply with the current editorial guidance.
Benzoic and salicylic acid ointment	A component that fails to comply with the current editorial guidance.
Benzoic and salicylic acid ointment	Ambiguous

Start Previous Page 162 of 1411 Next End

Reference Sets

Reference set descriptor

Back to Start

Id	Description	Lang	Type	Status	Case?	Module
900000000001066017	Concept inactivation indicator attribute value reference set	en	Synonym (core metadata concept)	Active	Entire term case insensitive (core metadata concept)	SNOMED CT model component module (core metadata concept)
900000000001067014	Concept inactivation indicator reference set	en	Synonym (core metadata concept)	Active	Entire term case insensitive (core metadata concept)	SNOMED CT model component module (core metadata concept)
900000000001068016	Concept inactivation indicator attribute value reference set (foundation metadata concept)	en	Fully specified name	Active	Entire term case insensitive (core metadata concept)	SNOMED CT model component module (core metadata concept)